Ninds, NIH BPN, NIH heal and other NIH neuroscience-focused drug discovery and development programs with toxicology consulting services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00652
- Awardee
-
Toxstrategies, LLC UEI FKS1YHGM3AN9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $393,023
Award facts
- Opportunity
-
- Toxicology Consulting Services Solicitation · NIHNINDS75N95022R00076 · Posted Aug 4, 2022
- Contract value 17% obligated
-
- $393,022.64 Current, with exercised options
- $2,347,472.64 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Austin, TX 78759, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$22,527 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,500 | |
| Exercise an Option | $166,600 | |
| Vendor DUNS or Name Change - Non-Novation | $73,500 | |
| Exercise an Option | $58,800 | |
| Other Administrative Action | $73,500 | |
| Original award | $41,650 |
About this award
The National Institute of Neurological Disorders and Stroke awarded a purchase order to Toxstrategies, LLC on September 20, 2022, for toxicology consulting services supporting the NIH Blueprint Neurotherapeutics Network, Helping to End Addiction Long-term Initiative, and other NIH neuroscience-focused drug discovery and development programs, with a ceiling value of $2,347,472.64.
Work is performed in Austin, Texas. The order procures senior-level toxicology consulting for drug discovery and early-stage development guidance, with preference for central nervous system and small molecule expertise. The solicitation estimated a base year commitment of 20 hours with optional additional hours up to 780 annually, plus $1,500 yearly for travel. Ultimate completion is scheduled for September 19, 2025.
Quick answers
Who was awarded contract 75N95022P00652?
75N95022P00652 was awarded to Toxstrategies, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2022.
How much is contract 75N95022P00652 worth?
The government has obligated $393,023 on 75N95022P00652. Its potential value, with all options, is $2,347,473.
Which agency awarded contract 75N95022P00652?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00652, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00652 competed?
The extent of competition for 75N95022P00652 was competed under sap. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award